'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Span Divergent Limited
SDL (BSE 524727) · ISIN INE004E01016 · Pharmaceuticals · Est. 1980 · listed 1995 · website
Not on any surveillance list
Next: Board meeting: financial results on 5 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹41.22 cr | ₹2.13 cr | ₹46.57 cr |
| 30 Sep 2025 standalone | ₹35.29 cr | ₹2.18 cr | ₹40.58 cr |
| 31 Mar 2025 standalone | ₹34.75 cr | ₹2.23 cr | ₹39.96 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 48.13% | — | — | 51.87% |
Latest filings
- Span Divergent Limited-E-voting result and Scrutinizer''s Report for the 46th Annual General Meeting held on Monday, September 28, 2026 29 September 2026 · BSE
- Span Divergent Limited-Summary of Proceedings of the Annual General Meeting held on September 28, 2026 28 September 2026 · BSE
- Span Divergent Limited-Notice of the 46th Annual General Meeting of the company scheduled to be held on Monday, September 28, 2026 2 September 2026 · BSE
- Annual Report FY2025-26 (New) 2 September 2026 · BSE
- Span Divergent Limited-Financial Results for the quarter end June 30, 2026 11 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.